Maven Securities’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,500
| Closed | -$524K | – | 248 |
|
|
2023
Q3 | $524K | Sell |
7,500
-27,500
| -79% | -$1.92M | 0.01% | 182 |
|
|
2023
Q2 | $2.52M | Buy |
+35,000
| New | +$2.52M | 0.04% | 70 |
|
|
2022
Q1 | – | Sell |
-17,017
| Closed | -$643K | – | 362 |
|
|
2021
Q4 | $643K | Buy |
+17,017
| New | +$643K | 0.02% | 176 |
|
|
2021
Q3 | – | Sell |
-27,548
| Closed | -$1.94M | – | 532 |
|
|
2021
Q2 | $1.94M | Buy |
+27,548
| New | +$1.94M | 0.08% | 124 |
|